Does ZIDOVUDINE Cause Myelosuppression? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Myelosuppression have been filed in association with ZIDOVUDINE (RETROVIR). This represents 0.2% of all adverse event reports for ZIDOVUDINE.
14
Reports of Myelosuppression with ZIDOVUDINE
0.2%
of all ZIDOVUDINE reports
1
Deaths
5
Hospitalizations
How Dangerous Is Myelosuppression From ZIDOVUDINE?
Of the 14 reports, 1 (7.1%) resulted in death, 5 (35.7%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZIDOVUDINE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ZIDOVUDINE Cause?
Foetal exposure during pregnancy (1,816)
Virologic failure (741)
Exposure during pregnancy (575)
Drug resistance (568)
Pathogen resistance (552)
Viral mutation identified (531)
Treatment failure (409)
Maternal exposure during pregnancy (395)
Anaemia (380)
Premature baby (367)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which ZIDOVUDINE Alternatives Have Lower Myelosuppression Risk?
ZIDOVUDINE vs ZILEUTON
ZIDOVUDINE vs ZILUCOPLAN
ZIDOVUDINE vs ZIMBERELIMAB
ZIDOVUDINE vs ZINC
ZIDOVUDINE vs ZINC\ZINC